Equitec Specialists Raised Its Teva Pharmaceutical Inds LTD (Put) (TEVA) Stake; Magicjack Vocaltec LTD (CALL) Sentiment Is 0.52

February 15, 2018 - By Linda Rogers

Equitec Specialists Llc increased Teva Pharmaceutical Inds Ltd (Put) (TEVA) stake by 611.9% reported in 2017Q3 SEC filing. Equitec Specialists Llc acquired 102,800 shares as Teva Pharmaceutical Inds Ltd (Put) (TEVA)’s stock declined 15.11%. The Equitec Specialists Llc holds 119,600 shares with $2.11M value, up from 16,800 last quarter. Teva Pharmaceutical Inds Ltd (Put) now has $19.64B valuation. The stock increased 4.37% or $0.81 during the last trading session, reaching $19.33. About 16.91 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 15, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

magicJack VocalTec Ltd., together with its subsidiaries, operates as a cloud communications firm in the United States. The company has market cap of $135.99 million. The companyÂ’s services and products allow users to make and/or receive free telephone calls to and from where the customer has broadband access to the Internet. It currently has negative earnings. It provides magicJack devices, such as The magicJack, magicJack PLUS, New magicJack PLUS, magicJack GO, and magicJack EXPRESS, which are voice-over-Internet-Protocol devices that enables clients to receive free VoIP phone service for their home, enterprise, or while traveling.

Equitec Specialists Llc decreased Cemex Sab De Cv (Prn) stake by 1.00M shares to 1.00 million valued at $1.14 million in 2017Q3. It also reduced Welltower Inc stake by 123,407 shares and now owns 212,712 shares. Zions Bancorporation (NASDAQ:ZIONW) was reduced too.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 145 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, January 20, the company rating was downgraded by JP Morgan. The firm has “Buy” rating by HSBC given on Monday, July 18. Guggenheim maintained the stock with “Hold” rating in Wednesday, January 31 report. The firm has “Hold” rating given on Friday, January 6 by Maxim Group. Credit Suisse downgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Tuesday, September 5 to “Sell” rating. BTIG Research downgraded the shares of TEVA in report on Wednesday, November 16 to “Neutral” rating. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Outperform” rating by Oppenheimer on Friday, September 2. The firm earned “Neutral” rating on Tuesday, September 29 by Nomura. The company was downgraded on Wednesday, November 16 by Jefferies. Goldman Sachs upgraded the stock to “Buy” rating in Monday, November 23 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Linda Rogers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: